Stable Istotope Labelled Perakizumab Biosimilar – Anti-IL17A mAb – Research Grade

Reference: PX-TA1301-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Istotope Labelled Perakizumab Biosimilar - Anti-IL17A mAb - Research Grade
SourceCAS 1331830-76-2
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsRG4934,RO5310074
ReferencePX-TA1301-SIL
Related ProductsPX-P4576
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-IL17A[Homo sapiens] (Perakizumab) Monoclonal Antibody

Perakizumab is humanized monoclonal antibody that targets IL17A. It has an immunomodulator activity and is used in the treatment of arthritis.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Perakizumab Biosimilar – Anti-IL17A mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below